Body Composition and Cancer Outcomes Research Webinar Series

The purpose of the Body Composition and Cancer Outcomes Research webinar series is to provide an opportunity for researchers and other interested individuals to share lessons learned, new methodologies, and new research integrating measures of body composition in cancer epidemiology research. This series is hosted by the Epidemiology and Genomics Research Program.

All interested individuals are invited to participate, however pre-registration is required. Each presentation will be about 30-40 minutes in length to allow for 20-30 minutes of discussion. Instructions for connecting to the webinars will be sent via e-mail to individuals who register.

Upcoming Topics and Speakers

June 16 2022

Body Composition Change in Pancreatic Cancer: Trajectory and Implications for Early Detection

3:00 p.m. to 4:00 p.m. ET

Ana Babic, Ph.D.External Web Site Policy
Dana-Farber Cancer Institute
Harvard School of Medicine

Michael Rosenthal, Ph.D., M.D.External Web Site Policy
Dana-Farber Cancer Institute
Harvard School of Medicine

Register for WebinarExternal Web Site Policy Need WebEx Assistance?

Past Topics and Speakers

2022

May 19 2022

Adverse Body Composition Changes That Affect Cancer Survivors: Detection, Devising Interventions That Work, and Measuring Impact

3:00 p.m. to 4:00 p.m. ET

Wendy Demark-Wahnefried, Ph.D., R.D.External Web Site Policy
Professor and Webb Endowed Chair of Nutrition Sciences, University of Alabama at Birmingham (UAB)
Associate Director of Cancer Prevention and Control, O'Neal Comprehensive Cancer Center at UAB

View Webinar Description

Dr. Demark-Wahnefried presented an overview of her research, ranging from observational studies that first documented sarcopenic obesity among cancer patients to diet, exercise, and weight management studies that improve body composition and result in improved outcomes among cancer survivors. She also discussed important questions surrounding communication with patients and the translation of research to clinical care and scalable interventions within the community.

Adverse Body Composition Changes That Affect Cancer Survivors: Detection, Devising Interventions That Work, and Measuring Impact

Apr 21 2022

Sarcopenia and Treatment Tolerability in Older Patients with Advanced Cancer

3:00 p.m. to 4:00 p.m. ET

Supriya G. Mohile, M.D., M.S.
Philip and Marilyn Wehrheim Professor of Medicine and Surgery
Director, Geriatric Oncology Research
Co-Program Leader, Cancer Prevention and Control Program
Wilmot Cancer Institute

Richard F. Dunne, M.D., M.S.
Assistant Professor of Medicine
Leader, Gastrointestinal Cancer Unit and Clinical Research
Wilmot Cancer Institute
University of Rochester Medical Center

View Webinar Description

Drs. Mohile and Dunne discussed their work examining the relationship between body composition and anti-cancer treatment tolerability in older adults with cancer.

Sarcopenia and Treatment Tolerability in Older Patients with Advanced Cancer

Mar 17 2022

Energy Balance in Colorectal Cancer: From Body Composition to Adipose-tumor Interactions

3:00 p.m. to 4:00 p.m. ET

Jennifer Ose, Ph.D., M.S.External Web Site Policy
Research Assistant Professor
Department of Population Health Sciences and Huntsman Cancer Institute
University of Utah

Cornelia M. Ulrich, Ph.D., M.S.External Web Site Policy
Chief Scientific Officer and Executive Director, Comprehensive Cancer Center, Huntsman Cancer Institute
Jon M. and Karen Huntsman Presidential Professor in Cancer Research, Department of Population Health Sciences, University of Utah

View Webinar Description

Drs. Ulrich and Ose presented their work from the ColoCare Study using body composition measures to understand colorectal cancer biology and clinical outcomes. They discussed their findings for CT-derived measures of body composition, biomarkers of angiogenesis and inflammation, as well as direct adipose tissue-tumor interaction.

Energy Balance in Colorectal Cancer: From Body Composition to Adipose-tumor Interactions

Feb 17 2022

Targeting Adipose Inflammation to Improve Breast Cancer Outcomes

3:00 p.m. to 4:00 p.m. ET

Neil M. Iyengar, M.D.External Web Site Policy
Associate Member & Attending Physician
Breast Medicine Service, Evelyn H. Lauder Breast and Imaging Center
Memorial Sloan Kettering Cancer Center

View Webinar Description

Dr. Iyengar presented his group’s research investigating the impact of adipose tissue biology on cancer progression. He discussed how adiposity alters the tumor microenvironment and ongoing intervention trials that seek to reduce adiposity, optimize body composition, and improve breast cancer outcomes.

Targeting Adipose Inflammation to Improve Breast Cancer Outcomes

Jan 20 2022

New Insights into Clinical Importance and Genetics of Body Fat Distribution

3:00 p.m. to 4:00 p.m. ET

Saaket Agrawal
Broad Institute

View Webinar Description

In this webinar, Saaket Agrawal discussed his work utilizing MRI-derived measurements of adiposity to understand disease associations and the genetic architecture of body fat distribution. He also discussed how an individual's outline can be used to estimate these adiposity measurements to provide disease prediction information independent of body mass index and waist circumference.

New Insights into Clinical Importance and Genetics of Body Fat Distribution

2021

Apr 15 2021

Body Composition in Cancer Epidemiology: Assessment, Associations and Future Directions

3:00 p.m. to 4:00 p.m. ET

Elizabeth Feliciano, ScD, MScExternal Web Site Policy
Kaiser Permanente Northern California

View Webinar Description

Dr. Feliciano presented an overview of her research examining body composition as an important risk factor for short- and long-term outcomes after a cancer diagnosis. She also discussed important questions surrounding this issue, including the biologic mechanisms that underlie these relationships, developing safe and accurate measures of body composition for use in the clinic, and how patient body composition is most relevant to clinical care.

Body Composition in Cancer Epidemiology: Assessment, Associations and Future Directions

Mar 11 2021

Defining and Managing Cachexia at the Individual Level

3:00 p.m. to 4:00 p.m. ET

Marcus DaSilva Goncalves, M.D., Ph.D.External Web Site Policy
Weill Cornell Medical College

View Webinar Description

Dr. Goncalves presented an overview of his clinical work assessing and managing cachexia in cancer patients. He used specific case examples and retrospective data to highlight potential weight management strategies.

Defining and Managing Cachexia at the Individual Level

Feb 11 2021

Body Composition and Treatment-Related Toxicities

3:00 p.m. to 4:00 p.m. ET

Michael Sawyer, M.D., B.Sc. PharmacyExternal Web Site Policy
Medical Oncologist and Clinical Pharmacologist, Cross Cancer Institute
Professor, Department of Oncology, Division of Medical Oncology, University of Alberta

View Webinar Description

Dr. Sawyer presented an overview of research describing how body composition contributes to treatment-related toxicities in cancer patients. Implications for drug dosing and metabolism were discussed.

Body Composition and Treatment-Related Toxicities

Jan 14 2021

Investigating the BMI Paradox in Kidney Cancer

3:00 p.m. to 4:00 p.m. ET

Helena Furberg, MSPH, Ph.D.External Web Site Policy
Memorial Sloan Kettering Cancer Center

View Webinar Description

Dr. Furberg discussed the body mass index (BMI) paradox in kidney cancer- where patients who have high BMI at diagnosis survive longer than patients who are classified as normal weight. She highlighted the research her group is doing related to the molecular underpinnings of this association and also described the RESOLVE Study which refines BMI into body composition features and transcriptomically profiles tumors from more than 1,000 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center to more accurately identify patients at highest mortality risk.

Investigating the BMI Paradox in Kidney Cancer

2020

Dec 17 2020

Automating Body Composition from Routinely Acquired CT images-towards 3D measurements

3:00 p.m. to 4:00 p.m. ET

Mirza Faisal Beg, Ph.D., P.EngExternal Web Site Policy
Simon Fraser University

View Webinar Description

Dr. Beg presented recent developments in automating body composition measurements from CT scans and discussed applications for research.

Automating Body Composition from Routinely Acquired CT images-towards 3D measurements

Nov 12 2020

Sarcopenia and Cancer Survival: Findings, Gaps, and Future Research

3:00 p.m. to 4:00 p.m. ET

Bette J. Caan, Dr.P.H.External Web Site Policy
Senior Research Scientist and Nutritional Epidemiologist
Kaiser Permanente Northern California, Division of Research

View Webinar Description

Dr. Caan presented an overview of the work to date on sarcopenia (loss of skeletal muscle mass and/or function) and cancer outcomes. She discussed methodological challenges and existing research gaps and identify future directions.

Sarcopenia and Cancer Survival: Findings, Gaps, and Future Research

Previous Body Composition and Cancer Webinar Series

A previous series of webinars, hosted by Dr. Bette Caan of Kaiser Permanente Northern California Division of Research, was held from 2018-2020.

Contact Us

We welcome questions about individual webinars or the series.

Contact the Planning Committee